FDA NDC Directory · JSON-LD · Markdown

Sincalide

NDC 70511-131 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerMAIA Pharmaceuticals, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA210850
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsSINCALIDE (5 ug/5mL)
Marketing started20221125
Package count1

External sources

Source: openFDA. Public-domain (CC0).